Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+4.4%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$168M |
| 2 |
Apple
AAPL
|
$71.3M |
| 3 |
Microsoft
MSFT
|
$57.4M |
| 4 |
HDFC Bank
HDB
|
$44.6M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
$40.5M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$83.3M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$81.2M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$43.3M |
| 4 |
Broadcom
AVGO
|
$42.7M |
| 5 |
Advanced Micro Devices
AMD
|
$37.7M |
Sector Composition
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
iShares Latin America 40 ETF
ILF
$1.78B
| $96.4K | ﹤0.01% |
4,600
+4,400
| +2,200% | +$92.2K |
|
1152
Merus
MRUS
$5.1B
| $96K | ﹤0.01% |
2,281
-186
| -8% | -$7.83K |
|
1153
Amicus Therapeutics
FOLD
$2.46B
| $95.9K | ﹤0.01% |
9,957
-770
| -7% | -$7.42K |
|
1154
Twist Bioscience
TWST
$1.55B
| $95.3K | ﹤0.01% |
1,978
-141
| -7% | -$6.79K |
|
1155
Ultrapar
UGP
$4.17B
| $95.1K | ﹤0.01% |
36,628
+3,423
| +10% | +$8.89K |
|
1156
TIM SA
TIMB
$10.3B
| $94.8K | ﹤0.01% |
8,072
+754
| +10% | +$8.86K |
|
1157
Janux Therapeutics
JANX
$1.44B
| $94.6K | ﹤0.01% |
1,749
-138
| -7% | -$7.47K |
|
1158
Vericel Corp
VCEL
$1.72B
| $94.3K | ﹤0.01% |
1,645
-128
| -7% | -$7.34K |
|
1159
Recursion Pharmaceuticals
RXRX
$2.01B
| $94K | ﹤0.01% |
12,721
-74,818
| -85% | -$553K |
|
1160
Acadia Pharmaceuticals
ACAD
$4.26B
| $94K | ﹤0.01% |
5,545
-454
| -8% | -$7.7K |
|
1161
Zillow
Z
$21.3B
| $93.9K | ﹤0.01% |
1,250
+579
| +86% | +$43.5K |
|
1162
EPR Properties
EPR
$4.05B
| $92.8K | ﹤0.01% |
2,113
-1,901
| -47% | -$83.5K |
|
1163
Edgewise Therapeutics
EWTX
$1.64B
| $90.7K | ﹤0.01% |
3,155
-237
| -7% | -$6.81K |
|
1164
Grupo Aeroportuario del Sureste
ASR
$10.2B
| $90.6K | ﹤0.01% |
346
+101
| +41% | +$26.5K |
|
|
SWTX
1165
DELISTED
SpringWorks Therapeutics
SWTX
| $90.1K | ﹤0.01% |
2,479
-207
| -8% | -$7.52K |
|
1166
Highwoods Properties
HIW
$3.44B
| $89.7K | ﹤0.01% |
2,958
-1,156
| -28% | -$35.1K |
|
1167
National Health Investors
NHI
$3.72B
| $88.8K | ﹤0.01% |
1,290
-4,161
| -76% | -$286K |
|
1168
Vanguard Real Estate ETF
VNQ
$34.7B
| $88.3K | ﹤0.01% |
1,000
| – | – |
|
1169
Vera Therapeutics
VERA
$1.54B
| $87.4K | ﹤0.01% |
2,110
+127
| +6% | +$5.26K |
|
1170
GDS Holdings
GDS
$6.35B
| $87.2K | ﹤0.01% |
3,706
-132
| -3% | -$3.11K |
|
1171
Douglas Emmett
DEI
$2.83B
| $87K | ﹤0.01% |
4,672
-1,825
| -28% | -$34K |
|
1172
Park Hotels & Resorts
PK
$2.4B
| $87K | ﹤0.01% |
5,830
-2,344
| -29% | -$35K |
|
1173
Kymera Therapeutics
KYMR
$3.11B
| $86.6K | ﹤0.01% |
2,158
-178
| -8% | -$7.14K |
|
1174
MINISO
MNSO
$7.49B
| $85.1K | ﹤0.01% |
3,562
-135
| -4% | -$3.22K |
|
1175
Robinhood
HOOD
$90B
| $84.1K | ﹤0.01% |
2,198
-41
| -2% | -$1.57K |
|